SCHEMBL596

SCHEMBL596

CCOC(=O)C(CC=O)C(=O)c1ccc(C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 5/20 0.40
HPGD P15428 2/20 0.40
RAB9A P51151 1/20 0.40
SLC6A3 Q01959 4/20 0.40
SLC6A2 P23975 3/20 0.40
LMNA P02545 3/20 0.40
GAA P10253 2/20 0.40
GSK3B P49841 1/20 0.40
SLC6A4 P31645 2/20 0.38
PKM P14618 2/20 0.38
HTT P42858 2/20 0.38
ATM Q13315 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
NLRP1 Q9C000 1/20 0.38
NTSR1 P30989 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10533897 0.93 SLC6A3 (0.47) KMT2AMEN1ALDH1A1HPGDRAB9A
SCHEMBL286 0.86 SLC6A3 (0.51) KMT2AMEN1ALDH1A1HPGDRAB9A
SCHEMBL9040524 0.77 ALDH1A1 (0.42) KMT2AMEN1ALDH1A1LMNAGAA
SCHEMBL7634475 0.77 KMT2A (0.49) KMT2AMEN1ALDH1A1HPGDRAB9A
SCHEMBL1822087 0.76 LMNA (0.43) KMT2AMEN1ALDH1A1HPGDLMNA
SCHEMBL28119887 0.75 LMNA (0.47) KMT2AMEN1ALDH1A1HPGDRAB9A
SCHEMBL9647321 0.74 MEN1 (0.49) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL1970298 0.73 KMT2A (0.44) KMT2AMEN1ALDH1A1HPGDRAB9A
SCHEMBL8791280 0.73 LMNA (0.46) KMT2AMEN1ALDH1A1HPGDRAB9A
SCHEMBL18017507 0.73 LMNA (0.44) KMT2AMEN1ALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733366-B1 Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics DU PONT (US) 1998-04-01 EP disclosed
EP-0324377-B1 Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids DU PONT (US) 1997-04-16 EP disclosed
EP-0733366-A2 Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-09-25 EP disclosed
EP-0253310-B1 Angiotensin II receptor blocking imidazoles DU PONT (US) 1994-10-26 EP disclosed
US-5155118-A Administering angiotensin inhibitor E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-10-13 US disclosed
US-5153197-A Treatment of hypertension with angiotensin II blocking imidazoles E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-10-06 US disclosed
US-5138069-A Treating hypertension and congestive heart failure E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-08-11 US disclosed
US-5128355-A Hypotensive E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-07-07 US disclosed
EP-0324377-A2 Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-07-19 EP disclosed
EP-0253310-A2 Angiotensin II receptor blocking imidazoles E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-01-20 EP disclosed